According to study authors, this electrical communication between skin cells may have the potential for therapeutic implications.
2023
Why men, wealthy people and maritime residents are more likely to develop skin cancer
A new study led by McGill University examines why people living in Atlantic regions are more at-risk for developing melanoma than other Canadians, providing lessons on skin cancer prevention for the whole country.
Nivolumab-Ipilimumab Increases Treatment-Free Survival in Advanced Melanoma
Patients with advanced melanoma receiving nivolumab in combination with ipilimumab as first-line treatment experience longer treatment-free survival than those receiving nivolumab or pembrolizumab monotherapy, according to a study published in JAMA Network Open.
Melanoma Treatment at Stage II Depends on Histologic Subtype
Researchers found significant difference in survival rates between lentigo maligna melanoma, nodular malignant melanoma, and superficial spreading melanoma.